Precision medicine promises tailor-made treatments, but it is difficult to predict why a therapeutic agent that improves or restores one patient’s health can fail for another. Progress in precision medicine is being hindered by the lack of understanding of how processes at the molecular and cellular level impact function at the tissue, organ or system level. Similarly, results obtained in well-controlled laboratory experiments can be unreliable predictors of behavior seen in complex dynamic in-vivo environments.
NIST can help address these challenges by building upon its expertise in imaging, including quantitative cellular imaging, digital pathology, spectroscopic imaging, PET/CT, MRI, and image analytics to improve and create a new generation of tools that measure complex dynamic biological processes.
- Identify technical challenges in imaging as applied to precision medicine where NIST can have significant impact
- Promote information exchange and connections between NIST researchers, leading to flagship collaborative projects in imaging for precision medicine
For more information: